Pathogenesis, natural history, treatment, and prevention of hepatitis C.
about
Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKRIdentification and targeting of an interaction between a tyrosine motif within hepatitis C virus core protein and AP2M1 essential for viral assemblyInterferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis CUnbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infectionImmunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzeesChronic hepatitis C: This and the new era of treatmentMolecular cancer prevention: Current status and future directionsHepatitis C virus (HCV) infection in Africa: a reviewThe advances in research on the pharmacological effects of Fructus Ligustri LucidiDaclatasvir: potential role in hepatitis CSuccess of antiviral therapy in chronic hepatitis C infection relates to functional status of myeloid dendritic cellsHCV-Mediated Apoptosis of Hepatocytes in Culture and Viral PathogenesisStrain-Specific T-Cell Suppression and Protective Immunity in Patients with Chronic Hepatitis C Virus InfectionHepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response.Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infectionInterleukin-1 Inhibits Hepatitis C Virus Subgenomic RNA Replication by Activation of Extracellular Regulated Kinase PathwayAmphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA ReplicationAlpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In VitroManaging Occupational Risks for Hepatitis C Transmission in the Health Care SettingImmunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virus-vaccinia infection.Small interfering RNA targeted to stem-loop II of the 5' untranslated region effectively inhibits expression of six HCV genotypesInterferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtypeDecreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis CDefective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis CAssociation of pretreatment serum interferon inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis CProduction of Infectious Hepatitis C Virus of Various Genotypes in Cell CulturesReduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in Hepatitis C virus repliconIdentification and In Vitro Expansion of Functional Antigen-Specific CD25+ FoxP3+ Regulatory T Cells in Hepatitis C Virus InfectionInteraction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus ParticlesHepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutationHepatic Transcriptome Analysis of Hepatitis C Virus Infection in Chimpanzees Defines Unique Gene Expression Patterns Associated with Viral ClearanceSynergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 BlockadePrevalence of HBV and HCV among blood donors in KosovoInteraction of hepatitis C virus envelope glycoprotein E2 with the large extracellular loop of tupaia CD81Functional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and CompartmentalizationPrevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.SInterferon modulation of cellular microRNAs as an antiviral mechanismHuman leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans
P2860
Q24292085-1AFE27EE-4642-4E1D-B030-046456251530Q24297412-2F4C972C-9F0B-42FB-AC78-EBFDEB93D1D5Q24530717-6B852F25-A325-49FD-8FBE-0B75C3DFE839Q24646403-B06F4AD2-55C4-4285-84D3-9D65AA0CC5F9Q24685256-DEA71F60-B100-48CE-B553-7F2240394E2EQ26775011-222E0357-EDA9-44DE-8002-D5EC972DB593Q26797207-2FA665D7-8569-4A9D-AD60-2534A243B557Q26824322-6AFFA67B-FAA3-438F-8BEA-4E1DC7880D2FQ27002425-63E9B108-3FEE-432F-A5BF-7AE59BB967B4Q27012741-86CA2774-E72B-402D-B620-5A986E3A6C97Q27023059-24A3D691-9F7D-4573-A1DD-2F493D23A24EQ27469084-7AAD137A-DA4E-416A-BC8E-7C1A8D955A79Q27469607-0FB1FA5E-DF8C-4E59-835C-C1BAAF3223DBQ27469808-A283FBCD-BAF0-42D9-A1A5-C6ADD4D0FA0FQ27472717-75828C34-E5C9-4415-8B4D-F43FF35B3E2EQ27472837-B8381DB6-CA62-44D4-9CE5-D50C3FE79A7FQ27473382-9BD30B2D-34B5-4D72-B30A-6A2FAA6778C2Q27473476-D558ADFA-FEBD-4BFE-A242-0E00D23DD2FDQ27473477-8B3A8F26-B5F5-475D-9BB1-729F2CEB5100Q27473519-3D42C148-820E-4E33-8DDF-30446D94909AQ27477626-617579BE-7F4F-4E7A-94D5-967B5E61243DQ27477660-DA592170-FC95-4668-BD20-86B0DBDC9568Q27477778-E8427B16-985E-4D97-8324-BE1BABCB5885Q27477854-4A4E77C8-75DA-4C8C-B3C9-877F9D92F834Q27478117-2B0F4287-ED86-41EC-A334-665BBB90A05AQ27478298-2E2F38DD-CC55-486B-ABE7-6B4AACAC1385Q27478305-9B96844B-4E7E-4DE1-BC6B-AE05C0E3F18CQ27480342-7967199B-7E17-43A7-9E06-3B0A199184A1Q27481650-02A48663-7D2D-42D9-830F-6FC0BEE3FC79Q27485897-2FA0FD85-8BB6-4807-8A0D-7FB83FB515DBQ27486780-F3E1085E-77F2-4D30-8F62-6E9198FB6298Q27486836-417D03AE-82D7-4396-AF40-172FC15B9994Q27487011-4A79AF40-AEE6-4F16-A479-D1FA52B159C1Q27487939-792CAE46-698B-4209-9804-F666936A3305Q27487972-35A502F2-BC09-4FD8-9CC5-5639A3D97308Q27488199-C28B83A5-5714-4E3D-87E2-0EE41931A459Q27488289-382F81A4-F498-4872-BA3D-BE1279B11C10Q27489610-50717BC6-8759-4793-BCCD-923E09E55D3AQ27489711-7E45CEB2-8BEA-4135-935A-0F7960F101E8Q27489728-D8C3C537-995E-4138-A72B-6D78E2257606
P2860
Pathogenesis, natural history, treatment, and prevention of hepatitis C.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pathogenesis, natural history, treatment, and prevention of hepatitis C.
@ast
Pathogenesis, natural history, treatment, and prevention of hepatitis C.
@en
type
label
Pathogenesis, natural history, treatment, and prevention of hepatitis C.
@ast
Pathogenesis, natural history, treatment, and prevention of hepatitis C.
@en
prefLabel
Pathogenesis, natural history, treatment, and prevention of hepatitis C.
@ast
Pathogenesis, natural history, treatment, and prevention of hepatitis C.
@en
P2093
P1476
Pathogenesis, natural history, treatment, and prevention of hepatitis C.
@en
P2093
Hoofnagle JH
Rehermann B
P304
P356
10.7326/0003-4819-132-4-200002150-00008
P407
P577
2000-02-01T00:00:00Z